SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-14-002175
Filing Date
2014-05-14
Accepted
2014-05-14 16:13:04
Documents
10
Period of Report
2014-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50864999.htm 8-K 18230
2 EXHIBIT 99.1 a50864999ex99_1.htm EX-99.1 44803
3 EXHIBIT 99.2 a50864999ex99_2.htm EX-99.2 11938
4 SLIDE 1 slide1.jpg GRAPHIC 183896
5 SLIDE 2 slide2.jpg GRAPHIC 556039
6 SLIDE 3 slide3.jpg GRAPHIC 148381
7 SLIDE 4 slide4.jpg GRAPHIC 221996
8 SLIDE 5 slide5.jpg GRAPHIC 211619
9 SLIDE 6 slide6.jpg GRAPHIC 261923
10 SLIDE 7 slide7.jpg GRAPHIC 217337
  Complete submission text file 0001157523-14-002175.txt   2559028
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 14841658
SIC: 2834 Pharmaceutical Preparations